QIAGEN is the leading provider of sample and assay technologies. Sample technologies are used to isolate DNA, RNA and proteins from any biological sample. Assay technologies are then used to make specific target biomolecules, such as the DNA of a specific virus, visible for subsequent analysis. We also provide you with dedicated solutions for your environmental testing workflow. Detection, quantification, and identification of microbial pathogens are prerequisites for water and environmental quality and safety control. Molecular analytical methods, such as real-time PCR, are increasingly being employed for detection of pathogens due to the shortened time to result and their potential to increase sensitivity and specificity.
We have developed and market more than 500 consumable products and automated solutions. The company provides these products to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal, environmental or food testing and pharmaceutical process control. QIAGEN's assay technologies include one of the broadest panels of molecular diagnostic tests available worldwide.
QIAGEN employs more than 3,600 people in over 35 locations worldwide.
As the innovative market and technology leader, QIAGEN creates sample and assay technologies that enable access to content from any biological sample.
Our mission is to enable our customers to achieve outstanding success and breakthroughs in life sciences, applied testing, pharma, and molecular diagnostics. We thereby make improvements in life possible.
Our commitment to the markets, customers, and patients we serve drives our innovation and leadership in all areas where our sample and assay technologies are required.
The exceptional talent, skill, and passion of our employees are key to QIAGEN’s excellence, success and value.